title: XIV. The rationale for combining targeted and biological anti-lymphoma drugs.
authors.affiliation: Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. younesa@mskcc.org
authors.forename: Anas
authors.initials: A
authors.lastname: Younes
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D058990:Molecular Targeted Therapy